Bernstein keeps telling clients to buy this pharma stock

July 11, 2026 4:00 AM

Bernstein estimates the potential market for drugs that stop protein ‘strangling’ of the heart (ATTR-CM) to be worth $20 billion ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found